September 26, 2024 September 26, 2024Categories Trial ResultsTrial Results: How one patient’s role in an ECOG-ACRIN study for acute lymphocytic leukemia brought a cancer-free diagnosis and FDA approvalAdding immunotherapy to standard chemotherapy keeps most patients with B-cell acute lymphoblastic leukemia in remission and improves their survival
July 2, 2024 July 2, 2024Categories Trial ResultsECOG-ACRIN research round-up – Summer 2024Takeaways from ECOG-ACRIN trial results presented at the 2024 American Society of Clinical Oncology Annual Meeting
March 26, 2024 March 26, 2024Categories Trial ResultsTrial Results: ECOG-ACRIN research round-up – Spring 2024Summaries of recent publications by researchers affiliated with ECOG-ACRIN
January 22, 2024 January 22, 2024Categories Trial ResultsTrial Results: A promising new approach may help women with DCIS determine their personal risk of developing invasive breast cancerA gene test helps identify women with high-risk DCIS who will likely benefit from radiation while informing those with low-risk disease about the possibility of safely skipping it